International Society of Microbiota

Your Social Circle Shapes Your Gut Microbiome 👥! Did you know that the people you spend time with can influence your gut microbiome? A groundbreaking Nature study shows that face-to-face interactions and shared meals drive the exchange of microbial strains, linking our social lives to gut health. Close relationships, like those between mothers and children, showed the highest microbial sharing, while larger social networks diluted this effect. This research uncovers a fascinating connection between social bonds and systemic health. Curious to learn how your relationships impact your microbiome? 🔗 : https://lnkd.in/dhjHw_m6 #InternationalSocietyofMicrobiota #ISM #Microbiome #GutHealth #SocialConnections #HealthResearch

Are dysfunctional mitochondria the key to understanding Crohn’s disease? A groundbreaking study from Dirk Haller and his team at Technical University of Munich reveals that defective mitochondria trigger tissue damage in the intestine and disrupt the microbiome, shedding new light on the causes of Crohn’s disease. This discovery could open the door for targeted treatments that focus on repairing mitochondrial function and restoring gut health. Read more: https://lnkd.in/diUeNEPX #InternationalSocietyofMicrobiota #ISM #CrohnsDisease #Mitochondria #GutHealth #microbiota #Microbiome #TUM #Research #ChronicInflammation #InnovativeTherapies

 Exploring the Mycobiome in Autism Spectrum Disorder wins Targeting Microbiota 2024 Best Poster! Vlasta Demeckova from Univerzita 'Pavla Jozefa Šafárika' v Košiciach, Slovakia, won the Best Poster Presentation Award at the Targeting Microbiota 2024 Conference for her research on mycobiome differences in Autism Spectrum Disorder. Her study, "Exploring The Mycobiome: Insights Into Fungal Community Differences Between Autism Spectrum Disorder and Healthy Individuals," highlights critical therapeutic targets, revealing lower fungal diversity and a dominance of Saccharomyces and Candida in ASD, emphasizing the essential role of mycobiota in immune regulation and gut health. Read more: https://lnkd.in/dykckgZn Congratulations to Dr. Demeckova on her groundbreaking research! 👏 #InternationalSocietyofMicrobiota #ISM #TargetingMicrobiota2024 #ResearchExcellence #Mycobiome #AutismResearch

Radio-Chemotherapy Worsens Gut Dysbiosis in Cervical Cancer Patients Impact of Radio-Chemotherapy on Intestinal Dysbiosis in Cervical Cancer Patients, #BestShortOralPresentation Award! Congrats to ksenia klimov, Universidad de Guadalajara, Mexico, for winning this award at #TargetingMicrobiota2024. In her presentation, she investigated how radio-chemotherapy exacerbates intestinal dysbiosis in cervical cancer patients from Western Mexico and its association with NK cell exhaustion. Findings indicate that treatment intensifies gut microbiota imbalances and promotes a pro-inflammatory environment, highlighting the potential for microbiome-targeted interventions to improve anti-tumor responses. #InternationalSocietyofMicrobiota #TargetingMicrobiota2024 #microbiomeresearch #microbiome #microbiota #guthealth #dysbiosis #cancer #cancertreatment

Bac3Gel® Lda won one of the Best Short Oral Presentation Awards at #TargetingMicrobiota2024 Congress! 🎉 Presentation: "Gut3Gel: Innovative in vitro Platform for Evaluating Microbiome-Modulating Molecules". Victoria Helena Navas Gil, representing the company, introduced Gut3Gel, an advanced in vitro platform designed to evaluate microbiome-modulating molecules, enhancing our understanding of gut interactions and their therapeutic potential. Bac3Gel, sponsor of the congress, is transforming wellness and healthcare with advanced 3D substrates and growth enhancers for microbiota culturing. Their innovative solutions simplify culturing processes and enable high-throughput screening, offering unique opportunities to harness the full potential of microbiota. The #ISM committee congratulates Dr. Navas and Bac3Gel on their innovation and award! #InternationalSocietyofMicrobiota #TargetingMicrobiota #microbiomeresearch #microbiome #microbiota #guthealth #nutraceuticals #innovation

ISM Best Scientific Contribution 2024: Decoding the Impact of Medications on Gut Microbiota! Dr. Carmelo Scarpignato from the United Campus of Malta & The Chinese University of Hong Kong has won the Best Scientific Contribution Award at the Targeting Microbiota 2024 Conference! Dr. Scarpignato's research explores how drugs, beyond antibiotics, like proton pump inhibitors (PPIs), NSAIDs, and statins can significantly disrupt gut microbiota, revealing that 24% of marketed drugs inhibit beneficial gut bacteria even at therapeutic doses. Dr. Scarpignato’s work in pharmacomicrobiomics is paving the way for precision medicine by showing the impact of microbiota on drug metabolism. #ISM congratulates Dr. Scarpignato! 🎉👏 🔗 : https://lnkd.in/dh5ebBru #TargetingMicrobiota2024 #Microbiota #microbiome #Pharmacology #PrecisionMedicine #Innovation

Decoding Microbiomes: Understanding Them as the Sum of Their Parts Anthony Duncan, Quadram Institute, UK, shared insights at #TargetingMicrobiota2024 on modeling microbiomes to reveal their collective behavior. By treating microbiomes as an aggregate of individual components, this approach sheds light on the complex interactions that shape microbial communities and their functions, enhancing our understanding of microbiome dynamics. #InternationalSocietyofMicrobiota #TargetingMicrobiota #microbiomeresearch #microbiome #microbiota #guthealth

Why Choose One? The Power of Combining 16S and mcrA Sequencing David Novák, Masaryk University Brno, Czech Republic, presented at #TargetingMicrobiota2024 on the advantages of integrating 16S and mcrA sequencing techniques. This dual approach enhances our understanding of microbial communities by providing comprehensive insights into both bacterial diversity and methanogen presence, paving the way for more nuanced microbiome research. #InternationalSocietyofMicrobiota #TargetingMicrobiota #microbiomeresearch #microbiome #microbiota #guthealth #sequencing

Understanding the Microbial Landscape in Ulcerative Colitis: Remission vs. Exacerbation Oliwia Zakerska-Banaszak, Institute of Human Genetics, Polish Academy of Sciences, shared data at #TargetingMicrobiota2024 on how microbial and metabolic profiles differ between remission and exacerbation phases in ulcerative colitis patients. This research aims to reveal potential biomarkers and therapeutic targets for better management of the condition. #InternationalSocietyofMicrobiota #TargetingMicrobiota #microbiomeresearch #microbiome #microbiota #guthealth

Psychobiotic and Antidiabetic Benefits: The Power of Probiotics and Prebiotics Ashwinipriyadarshini Megur, Vilniaus universitetas / Vilnius University, Lithuania, presented findings on the synergistic effects of Lacticaseibacillus paracasei 11w and galactooligosaccharides at #TargetingMicrobiota2024. This study highlights their combined efficacy in enhancing psychobiotic and antidiabetic outcomes in female mice, shedding light on innovative approaches to gut health. #InternationalSocietyofMicrobiota #TargetingMicrobiota #microbiomeresearch #microbiome #microbiota #guthealth #psychobiotics